Join the club for FREE to access the whole archive and other member benefits.

Christoph Antz

CEO of Velabs Therapeutics.

Christoph is an experienced company executive and former venture capital manager in the fields of life sciences with special focus on drug development (small molecules and biologicals), diagnostics and instrumentation.

Before joining Velabs, he was CEO and Managing Director of different companies like Luxendo (light sheet microscopy), Acousia Therapeutics (inner ear drug development), Abeta (Alzheimer diagnostics) and EMBL Ventures (venture capital fund), being instrumental in company build-up, strategy implementation and financing up to successful M&A. He holds a Ph.D. in physics (structural biology) from the University of Heidelberg and did postdoctoral studies at the University of California, San Francisco (rational drug development). Christoph is an alumnus of the Max-Planck-Institute for Medical Research, Heidelberg.

Visit website:

 Login to view link, or join the club to get full access to all resources and other benefits.

See also: Company Velabs Therapeutics - Fast generation of functional therapeutic antibodies.

Christoph Antz News

Labiotech gathers feedback from European biotechs on Unity failure

Labiotech - 28-Aug-2020

General feeling that failures are bound to happen - but that their approaches can succeed